iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Centaurus Financial Inc.

Centaurus Financial Inc. reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 17.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,039 shares of the financial services provider’s stock after selling 224 shares during the quarter. Centaurus Financial Inc.’s holdings in iShares Biotechnology ETF were worth $141,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the business. First Horizon Advisors Inc. increased its stake in iShares Biotechnology ETF by 5.5% during the fourth quarter. First Horizon Advisors Inc. now owns 2,193 shares of the financial services provider’s stock worth $298,000 after acquiring an additional 115 shares during the last quarter. Pinnacle Wealth Management Advisory Group LLC increased its stake in iShares Biotechnology ETF by 8.3% during the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,931 shares of the financial services provider’s stock worth $262,000 after acquiring an additional 148 shares during the last quarter. Corient Private Wealth LLC increased its stake in iShares Biotechnology ETF by 1.0% during the fourth quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock worth $11,778,000 after acquiring an additional 841 shares during the last quarter. Great Valley Advisor Group Inc. increased its stake in iShares Biotechnology ETF by 14.1% during the fourth quarter. Great Valley Advisor Group Inc. now owns 2,786 shares of the financial services provider’s stock worth $378,000 after acquiring an additional 344 shares during the last quarter. Finally, Premier Path Wealth Partners LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth about $207,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $134.38 on Thursday. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16. The business has a 50-day moving average of $132.95 and a two-hundred day moving average of $134.21.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.